I-Mab
NASDAQ:IMAB

Watchlist Manager
I-Mab Logo
I-Mab
NASDAQ:IMAB
Watchlist
Price: 4.15 USD 1.97% Market Closed
Market Cap: 338.9m USD

Operating Margin
I-Mab

0%
Current
-171%
Average
-4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-37.4m
/
Revenue
0

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
CN
I-Mab
NASDAQ:IMAB
338.9m USD N/A
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
396.4B USD
33%
US
Amgen Inc
NASDAQ:AMGN
175.4B USD
34%
US
Gilead Sciences Inc
NASDAQ:GILD
150.7B USD
39%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.2B USD
39%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79B USD
28%
AU
CSL Ltd
ASX:CSL
84B AUD
26%
NL
argenx SE
XBRU:ARGX
45.6B EUR
22%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
51.7B USD
8%
No Stocks Found

I-Mab
Glance View

Market Cap
338.9m USD
Industry
Biotechnology

I-Mab operates as a clinical stage biopharmaceutical company. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-01-17.

IMAB Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-37.4m
/
Revenue
0
What is the Operating Margin of I-Mab?

Based on I-Mab's most recent financial statements, the company has Operating Margin of 0%.

Back to Top